We are live on
!
Find out more
SCM
Suffolk Capital Management Portfolio holdings
AUM
$521M
1-Year Est. Return
9.79%
This Fund
S&P 500
This Quarter
Est. Return
+9.13%
1 Year Est. Return
-9.79%
3 Year Est. Return
+48.57%
5 Year Est. Return
+94.78%
10 Year Est. Return
–
AUM
$726M
AUM Growth
-$50M
(-6.4%)
Cap. Flow
-$99.5M
Cap. Flow
% of AUM
-13.7%
Top 10 Holdings %
Top 10 Hldgs %
24.04%
Holding
169
New
31
Increased
18
Reduced
81
Closed
35
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$14.2M |
| 2 |
Apple
AAPL
|
+$14.2M |
| 3 |
T-Mobile US
TMUS
|
+$12.4M |
| 4 |
Biogen
BIIB
|
+$11.8M |
| 5 |
Kraft Heinz
KHC
|
+$11.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$13.5M |
| 2 |
IBM
IBM
|
+$12.9M |
| 3 |
AET
Aetna Inc
AET
|
+$12.1M |
| 4 |
MGM Resorts International
MGM
|
+$11.5M |
| 5 |
Prudential Financial
PRU
|
+$10.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.48% |
| 2 | Technology | 17.46% |
| 3 | Industrials | 14.34% |
| 4 | Consumer Discretionary | 12.95% |
| 5 | Communication Services | 12.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MZOR
76
DELISTED
Mazor Robotics Ltd.
MZOR
| $1.65M | 0.23% |
+63,940
| New | +$1.42M |
|
77
MacroGenics
MGNX
$235M
| $1.64M | 0.23% |
54,717
-3,293
| -6% | -$97.9K |
|
78
Prestige Consumer Healthcare
PBH
$2.38B
| $1.62M | 0.22% |
33,579
-13,259
| -28% | -$671K |
|
79
Zurn Elkay Water Solutions
ZWS
$8.38B
| $1.62M | 0.22% |
157,195
-126,304
| -45% | -$1.28M |
|
80
Helen of Troy
HELE
$644M
| $1.61M | 0.22% |
+18,674
| New | +$1.75M |
|
81
Ligand Pharmaceuticals
LGND
$5.76B
| $1.59M | 0.22% |
24,938
-7,855
| -24% | -$577K |
|
82
G-III Apparel Group
GIII
$1.54B
| $1.55M | 0.21% |
53,199
-16,701
| -24% | -$656K |
|
|
AIRM
83
DELISTED
Air Methods Corp
AIRM
| $1.54M | 0.21% |
+48,800
| New | +$1.66M |
|
|
CSOD
84
DELISTED
Cornerstone OnDemand, Inc.
CSOD
| $1.52M | 0.21% |
32,986
-28,000
| -46% | -$1.23M |
|
85
Fabrinet
FN
$15.6B
| $1.51M | 0.21% |
+33,800
| New | +$1.34M |
|
86
Pacira BioSciences
PCRX
$1.04B
| $1.51M | 0.21% |
+44,000
| New | +$1.72M |
|
|
CAVM
87
DELISTED
Cavium, Inc.
CAVM
| $1.5M | 0.21% |
25,828
-34,053
| -57% | -$1.7M |
|
88
Power Integrations
POWI
$3.38B
| $1.49M | 0.21% |
47,264
-59,314
| -56% | -$1.69M |
|
|
CALD
89
DELISTED
Callidus Software, Inc.
CALD
| $1.49M | 0.21% |
+81,208
| New | +$1.59M |
|
|
AJRD
90
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $1.49M | 0.2% |
84,654
-69,194
| -45% | -$1.25M |
|
|
RVNC
91
DELISTED
Revance Therapeutics, Inc.
RVNC
| $1.48M | 0.2% |
91,194
-67,618
| -43% | -$982K |
|
92
Five Below
FIVE
$12B
| $1.48M | 0.2% |
+36,663
| New | +$1.7M |
|
93
B&G Foods
BGS
$287M
| $1.48M | 0.2% |
+30,001
| New | +$1.44M |
|
94
Astronics
ATRO
$3.43B
| $1.46M | 0.2% |
51,385
-42,892
| -45% | -$1.1M |
|
95
Celldex Therapeutics
CLDX
$2.99B
| $1.46M | 0.2% |
24,020
-7,633
| -24% | -$475K |
|
96
MGP Ingredients
MGPI
$379M
| $1.44M | 0.2% |
35,442
-28,185
| -44% | -$1.09M |
|
97
J&J Snack Foods
JJSF
$1.43B
| $1.44M | 0.2% |
12,043
-17,500
| -59% | -$2.11M |
|
|
IPHI
98
DELISTED
INPHI CORPORATION
IPHI
| $1.43M | 0.2% |
32,897
-53,316
| -62% | -$2.06M |
|
|
IDTI
99
DELISTED
Integrated Device Technology I
IDTI
| $1.42M | 0.2% |
61,604
-54,169
| -47% | -$1.12M |
|
|
MSCC
100
DELISTED
Microsemi Corp
MSCC
| $1.42M | 0.2% |
33,873
-51,648
| -60% | -$1.98M |
|
Similar funds
CFIC
MCTIC
BTNA
RCM
OTC
SFM
APFBOT
NCMW
Suffolk Capital Management's Q3 2016 Portfolio in Review
As of Q3 2016, Suffolk Capital Management held 169 positions worth $726M, down 6.4% from $776M the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Suffolk Capital Management withdrew a net $99.5M in Q3 2016, closing 35 positions and reducing 81 holdings. Its most notable exit was Humana, an estimated $13.5M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Technology and Industrials.
Against the trend, Suffolk Capital Management opened a new position in IVERIC bio, Inc. Common Stock worth $11.6M.
- Suffolk Capital Management's largest Q3 2016 buy was IVERIC bio, Inc. Common Stock: 252,355 shares worth $11.6M.
- Suffolk Capital Management added most to Apple in Q3 2016, an estimated $14.2M increase.
- Suffolk Capital Management's biggest Q3 2016 reduction was TESARO, Inc., cutting an estimated $8.8M.
- Suffolk Capital Management fully exited Humana in Q3 2016, selling an estimated $13.5M.
- Suffolk Capital Management's ten largest holdings make up 24% of its $726M portfolio in Q3 2016.
- Suffolk Capital Management opened 31 new positions and closed 35 in Q3 2016.
- Suffolk Capital Management's portfolio value fell 6.4% quarter-over-quarter to $726M.
Based on Suffolk Capital Management's 13F filing for Q3 2016, filed 31 Oct 2016.